Mark D. Minden

Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B

John B. MacMillan, Rolf A. Brekken, M. Minden, 2015, Nature chemical biology.

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

Tak W. Mak, Lenny Dang, Masato Sasaki, 2010, The Journal of experimental medicine.

Corrigendum: Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia

Thomas J. Hudson, Lincoln D. Stein, Liran I. Shlush, 2014, Nature.

A 17-gene stemness score for rapid determination of risk in acute leukaemia

Claude Preudhomme, Peter W. Zandstra, Bob Löwenberg, 2016, Nature.

Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells

James R. Downing, Jing Ma, Sergei Doulatov, 2011, Nature.

Metabolic Adaptation to Chronic Inhibition of Mitochondrial Protein Synthesis in Acute Myeloid Leukemia Cells

Gary D. Bader, Gary D Bader, Mahadeo A. Sukhai, 2013, PloS one.

Sensitive tumour detection and classification using plasma cell-free DNA methylomes

Rajat Singhania, Dianne Chadwick, Anna Goldenberg, 2018, Nature.